MLTX vs. MMYT

In the year-to-date period, MLTX achieves a -28.96% return, which is significantly lower than MMYT's -12.79% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and MakeMyTrip Limited (MMYT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MLTX Sharpe Ratio is -0.17, which is lower than the MMYT Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of MLTX and MMYT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither MLTX nor MMYT has paid dividends to shareholders.

The maximum MLTX drawdown since its inception was -64.60%, smaller than the maximum MMYT drawdown of -73.45%. Use the drawdown chart below to compare losses from any high point for MLTX and MMYT. For additional features, visit the drawdowns tool.

The current volatility for MoonLake Immunotherapeutics (MLTX) is 15.34%, while MakeMyTrip Limited (MMYT) has a volatility of 18.69%. This indicates that MLTX experiences smaller price fluctuations and is considered to be less risky than MMYT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and MakeMyTrip Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.